{"id":801,"date":"2026-07-15T07:35:38","date_gmt":"2026-07-15T07:35:38","guid":{"rendered":"https:\/\/isbmblowmolding.com\/?p=801"},"modified":"2026-07-16T01:36:31","modified_gmt":"2026-07-16T01:36:31","slug":"pharmaceutical-liquid-bottle-blow-molding-machine","status":"publish","type":"post","link":"https:\/\/isbmblowmolding.com\/it\/application\/pharmaceutical-liquid-bottle-blow-molding-machine\/","title":{"rendered":"Three-Station Blow Molding Machine for Pharmaceutical Liquid Bottles | Oral Liquid, Syrup & Eye Drop Packaging"},"content":{"rendered":"
\n

<\/p>\n

\n

Industry Application Series \u2014 Pharmaceutical & Medical Packaging<\/p>\n<\/div>\n

<\/p>\n

Three-Station Blow Molding Machine for Pharmaceutical Liquid Bottles: Oral Liquid, Syrup & Eye Drop Packaging<\/h2>\n

In pharmaceutical packaging, there is almost no room for error. A bottle that fails to seal correctly, presents inconsistent wall thickness, or carries invisible microbial contamination can compromise drug efficacy, trigger regulatory action, and put patients at risk. For manufacturers producing oral liquid bottles, syrup bottles, and eye drop containers at industrial scale, the choice of production technology is not merely a procurement decision \u2014 it is a quality assurance commitment that reaches all the way to the end patient.<\/p>\n

The Macchina per stampaggio a soffiaggio a tre stazioni<\/a> from AUS isbmblowmolding Co., Ltd \u2014 represented by the HGY50-V3-EV model \u2014 has become a preferred production platform for pharmaceutical packaging lines worldwide. This article examines why the three-station one-step ISBM (Injection Stretch Blow Molding) process is specifically well-suited to pharmaceutical liquid bottle production, and what manufacturers in Australia, the UK, the Netherlands, and other regulated markets need to understand before specifying this equipment.<\/p>\n

\"\"<\/p>\n

<\/p>\n

Why Pharmaceutical Liquid Packaging Demands One-Step ISBM<\/h2>\n

Pharmaceutical liquid bottles \u2014 including 30 ml oral solution bottles, 100 ml syrup bottles, and small-volume ophthalmic dropper containers \u2014 share three non-negotiable production requirements: dimensional precision at the neck and thread finish, uniform wall thickness across the entire bottle body, and a contamination-controlled production environment compliant with GMP (Good Manufacturing Practice) standards.<\/p>\n

Traditional two-stage blow molding processes, where preforms are injection-moulded in one machine, cooled, stored, transported, and then reheated in a separate blow moulding machine, introduce multiple contamination and quality risk points. Every handling step between the injection stage and the blow stage is an opportunity for particulate deposition, moisture absorption, and dimensional distortion due to uneven reheating. For non-critical consumer bottles, this is acceptable. For pharmaceutical liquid packaging, it is not.<\/p>\n

The one-step three-station process of the HGY50-V3-EV eliminates every one of these intermediate steps. Plastic resin \u2014 typically PET or PETG of pharmaceutical grade \u2014 enters the injection station, is moulded into a preform, rotates 120\u00b0 to the stretch-blow station while retaining its injection heat, is simultaneously stretched axially and blown radially into the final bottle shape, then rotates another 120\u00b0 to the ejection station. The entire sequence occurs within a single sealed machine environment, with no intermediate handling, no reheating oven, and no exposure to factory atmosphere between process stages.<\/p>\n

The result is a bottle produced in a closed-loop, parameter-controlled environment \u2014 precisely the kind of process traceability that GMP auditors and regulatory bodies such as the Australian TGA, UK MHRA, and the Netherlands’ MEB require for drug packaging validation.<\/p>\n

<\/p>\n

Specific Bottle Types and Their Production Requirements<\/h2>\n

Oral Liquid and Syrup Bottles (30 ml \u2013 500 ml)<\/h3>\n

Oral liquid and syrup formulations \u2014 paediatric antibiotics, antitussives, vitamin supplements \u2014 are typically packaged in PET bottles ranging from 30 ml to 500 ml. These bottles require a precision-moulded 28 mm or 38 mm neck finish to accept child-resistant closures and dosing cup adapters. Wall thickness variation must remain within \u00b10.05 mm across the bottle body to ensure consistent product barrier performance and to prevent premature cracking during transportation.<\/p>\n

The five-servo-system configuration of the HGY50-V3-EV (using Inovance\/MiRLE servo drives) delivers the injection pressure consistency and mould clamping stability required to maintain these tight tolerances across multi-cavity production runs of six bottles per cycle. The PLC-controlled process parameters \u2014 injection temperature, stretch rod speed, blow air pressure, and cooling duration \u2014 are logged digitally and can be exported for batch record documentation, directly supporting pharmaceutical manufacturers’ GMP documentation requirements.<\/p>\n

Eye Drop and Ophthalmic Solution Bottles (5 ml \u2013 30 ml)<\/h3>\n

Ophthalmic packaging represents perhaps the most demanding sub-category within pharmaceutical liquid bottles. Eye drop bottles must combine a precisely moulded dropper neck (typically 13 mm or 18 mm finish) with a body transparent enough to allow volume verification, walls thin enough to allow squeeze dispensing, yet structurally intact enough to withstand the sterilisation cycles used in ophthalmology filling lines.<\/p>\n

PETG is frequently specified for ophthalmic bottles because it offers the glass-like optical clarity required for product visibility, chemical resistance to the aqueous formulations and preservatives used in eye drops, and sufficient flexibility for squeeze dispensing without stress whitening. The HGY50-V3-EV’s ability to process both PET and PETG on the same platform \u2014 switching between materials via screw and temperature profile changes \u2014 gives pharmaceutical manufacturers production flexibility without requiring a second machine investment.<\/p>\n

<\/p>\n

Key Technical Advantages for Pharmaceutical Applications<\/h2>\n

<\/p>\n

\n
\n

Zero Flash, Zero Trimming<\/p>\n

The injection blow process produces a fully finished neck with no flash waste and no secondary trimming operation, eliminating a major particulate contamination risk in cleanroom environments.<\/p>\n<\/div>\n

\n

Uniform Wall Thickness<\/p>\n

Biaxial molecular orientation during the stretch-blow stage produces consistent wall thickness distribution, critical for maintaining drug barrier properties and meeting container specification requirements in pharmacopoeial testing.<\/p>\n<\/div>\n

\n

GMP-Compatible Process Control<\/p>\n

Inovance PLC with HMI touchscreen logs all critical process parameters. Data export capability supports pharmaceutical batch record documentation and regulatory audit readiness.<\/p>\n<\/div>\n

\n

No Hydraulic Oil Contamination<\/p>\n

The all-electric servo drive configuration (EV model) eliminates hydraulic oil from the machine, removing a significant contamination risk in pharmaceutical production environments and facilitating ISO cleanroom integration.<\/p>\n<\/div>\n<\/div>\n

<\/p>\n

Regulatory Compliance Context for Key Markets<\/h2>\n

Pharmaceutical packaging manufacturers operating across different geographies must align their production equipment and processes with local regulatory frameworks. The one-step ISBM process offers a documentation and process control architecture that maps well to the most common international standards.<\/p>\n